top of page
Apr 23, 2024
Navigating Challenges in the Development of ADA Assays for Immunogenicity Studies
In the realm of biopharmaceutical development, understanding and mitigating the immunogenicity of therapeutic proteins is crucial for...
Apr 18, 2024
Fleet Bioprocessing re-certified to Cyber Essentials
Fleet Bioprocessing has successfully been re-certified as meeting the standards of Cyber Essentials. Cyber Essentials is a Government...
Apr 5, 2024
Choosing the Right Platform for ADA Assays in Immunogenicity Studies: A Critical Decision
In the realm of biopharmaceutical development, understanding and mitigating the immunogenicity of therapeutic proteins is paramount....
Feb 26, 2024
Streamlining Success: The Compelling Reasons to Outsource Bioconjugation and Antibody Labelling
In the dynamic landscape of life sciences and diagnostics, bioconjugation and antibody labelling stand as critical processes in advancing...
Jan 31, 2024
Unlocking Efficiency: Reasons to Outsource Immunoassay and ELISA Development
In the rapidly evolving landscape of life sciences and diagnostics, immunoassays and ELISAs play a pivotal role in detecting and...
Jan 17, 2024
Fleet to attend London Biotechnology Show in May
Fleet Bioprocessing Ltd. will be going to the London Biotechnology Show, to be held at Olympia on 8th - 9th May 2024. We'd love to talk...
bottom of page